Table 1:

The clinical and pathological characteristics of CR patients.

	CR patients
Characteristics/number	1	2	3	4	5	6	7	8	9
Age at diagnosis, years	60	58	56	74	52	65	59	74	67
Gender	M	M	F	F	M	M	M	M	M
Course of disease, years	5	4	4	4	3	4	2	2	2
BMI at diagnosis, kg/m2	24.6	26.3	24.8	27.5	25.1	22.2	26	24.5	23.7
BP at diagnosis, mmHg	160/106	150/80	118/90	133/77	120/70	165/90	156/82	150/81	140/82
eGFR at diagnosis, mL/min/1.73 m2 (CKD-EPI)	89.2	61.3	101.3	74.8	102.8	58.7	63.7	58.2	61.9
Creatinine at diagnosis, µmol/L	82	113	54	69	75	112	109	108	107
24 h UTP at diagnosis, g/day	11.2	7.54	4.99	7.48	3.68	9.85	8.84	9.2	4.34
Albumin at diagnosis, g/L	14.1	32.1	20.5	25.3	23.2	16	17.2	15	22.9
Serum PLA2R at diagnosis, RU/mL	ND	24.37	62.09	0.87	ND	49.29	427.98	53.43	34.07
Complication	Hypertension	Hypertension/diabetes	No	Hypertension	No	Hypertension	Hypertension	Hypertension	Gout
Immunosuppressor	CTX	Tacrolimus/CTX	CTX/rituximab	Tacrolimus	CTX	CTX/Tacrolimus	Tacrolimus	Rituximab	CTX
MN class	I	I–II	I	II	I	I	I	II	II
IF IgG	3+	3+	3+	3+	3+	3+	3+	3+	3+
IF IgA	Neg	Neg	Neg	Neg	Neg	Neg	Neg	Neg	Neg
IF C3	3+	2+	1+	2+	Neg	2+	2+	2+	3+
IF C1q	Neg	Neg	Neg	Neg	Neg	Neg	Neg	Neg	Neg
Tissue PLA2R	Neg	Pos	Pos	Pos	Pos	Pos	Pos	Pos	Pos
Global sclerosis (%)	10	9	0	6	4	0	6	0	0
Segmental sclerosis	0/10	0/32	0/3	0/20	0/28	1/6	0/17	0/21	0/16
Crescent	0/10	0/32	0/3	0/20	0/28	0/6	0/17	0/21	0/16
Interstitial fibrosis (%)	5	5	0	10	0	15	10	10	5
Mesangial matrix increase	Neg	Mild	Neg	Neg	Mild	Neg	Neg	Mild	neg
Interstitial lymphocytes	Neg	Neg	Mild	Mild	Neg	Mild	Mild	Mild	Mild
Arterial sclerosis	Mild	Mild	Mild	Mild	Mild	Neg	Mild	Mild	Neg

M: male; F: female; BMI: body mass index BP: blood pressure; UTP: urine total protein; CTX: cyclophosphamide; Neg: negative; Pos: positive.